Fidelity Investments’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-3,009
| Closed | -$12.6K | – | 5706 |
|
|
2023
Q1 | $12.6K | Sell |
3,009
-3,335
| -53% | -$17.3K | ﹤0.01% | 4037 |
|
|
2022
Q4 | $38.1K | Sell |
6,344
-80,724
| -93% | -$441K | ﹤0.01% | 3528 |
|
|
2022
Q3 | $507K | Buy |
87,068
+86,998
| +124,283% | +$542K | ﹤0.01% | 2779 |
|
|
2022
Q2 | $0 | Buy |
70
+53
| +312% | +$271 | ﹤0.01% | 5771 |
|
|
2022
Q1 | $0 | Buy |
+17
| New | +$51 | ﹤0.01% | 5750 |
|
|
2018
Q4 | – | Sell |
-949,700
| Closed | -$2.05M | – | 4490 |
|
|
2018
Q3 | $2.05M | Sell |
949,700
-450,300
| -32% | -$1.11M | ﹤0.01% | 2364 |
|
|
2018
Q2 | $6.97M | Hold |
1,400,000
| – | – | ﹤0.01% | 2050 |
|
|
2018
Q1 | $5.46M | Buy |
+1,400,000
| New | +$4.92M | ﹤0.01% | 2135 |
|
|
2017
Q1 | – | Sell |
-95,237
| Closed | -$384K | – | 2784 |
|
|
2016
Q4 | $384K | Sell |
95,237
-384,763
| -80% | -$1.6M | ﹤0.01% | 2568 |
|
|
2016
Q3 | $1.8M | Sell |
480,000
-664,526
| -58% | -$2.42M | ﹤0.01% | 2384 |
|
|
2016
Q2 | $3.89M | Sell |
1,144,526
-1,233,699
| -52% | -$5.66M | ﹤0.01% | 2240 |
|
|
2016
Q1 | $12.6M | Sell |
2,378,225
-413,747
| -15% | -$3.31M | ﹤0.01% | 1856 |
|
|
2015
Q4 | $34.3M | Buy |
2,791,972
+1,816,577
| +186% | +$24.3M | ﹤0.01% | 1416 |
|
|
2015
Q3 | $14.2M | Buy |
975,395
+83,324
| +9% | +$1.44M | ﹤0.01% | 1801 |
|
|
2015
Q2 | $17.4M | Buy |
892,071
+62,902
| +8% | +$1.21M | ﹤0.01% | 1788 |
|
|
2015
Q1 | $15M | Buy |
829,169
+489,956
| +144% | +$11M | ﹤0.01% | 1855 |
|
|
2014
Q4 | $8.01M | Hold |
339,213
| – | – | ﹤0.01% | 2082 |
|
|
2014
Q3 | $8.21M | Hold |
339,213
| – | – | ﹤0.01% | 2079 |
|
|
2014
Q2 | $9.53M | Sell |
339,213
-24,010
| -7% | -$722K | ﹤0.01% | 2071 |
|
|
2014
Q1 | $12.3M | Sell |
363,223
-262,020
| -42% | -$8.95M | ﹤0.01% | 1948 |
|
|
2013
Q4 | $12M | Hold |
625,243
| – | – | ﹤0.01% | 1909 |
|
|
2013
Q3 | $10.3M | Hold |
625,243
| – | – | ﹤0.01% | 1942 |
|
|
2013
Q2 | $6.57M | Buy |
+625,243
| New | +$7.33M | ﹤0.01% | 2049 |
|
Other funds holding CTIC
Fidelity Investments's CTIC Position: Q2 2023 in Review
Fidelity Investments sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 3,009 shares — an estimated $12.6K sold.
Fidelity Investments first reported a position in CTIC in Q2 2013 and held it in 23 quarters. The position peaked at $34.3M in Q4 2015. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- Fidelity Investments reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- Fidelity Investments sold 3,009 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $12.6K.
- Fidelity Investments first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 23 quarters.
- Fidelity Investments's CTI BioPharma Corp. (DE) Common Stock position peaked at $34.3M in Q4 2015.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.